文献速递产科母胎医学

妊娠期糖尿病后2型糖尿病发病的种族和民族不平等

Racial and Ethnic Inequities in Development of Type 2 Diabetes After Gestational Diabetes Mellitus.
PubMed 文献 · Obstet Gynecol · 2023-09-07

该回顾性队列纳入2009-2011年纽约市22,338例妊娠期糖尿病(GDM)患者,链接2009-2017年A1c登记数据,发现8年2型糖尿病累积发病率为11.7%,黑人、南亚及东南亚裔、西班牙裔较白人风险显著升高,妊娠期临床及社会结构特征部分解释差异。

要点

  • GDM后8年2型糖尿病总体发病率为11.7%,黑人18.5%、南亚及东南亚裔16.8%、西班牙裔14.6%、东亚及中亚裔5.5%、白人5.4%。
  • 校正年龄和出生地后,黑人、南亚及东南亚裔、西班牙裔较白人的调整风险比分别为4.0、2.9、3.3,东亚及中亚裔为1.0。
  • 妊娠期临床特征和社会结构特征分别解释黑人差异的9.3%和23.8%、西班牙裔的31.2%和24.7%、南亚及东南亚裔的7.6%和16.3%。

核心结论

  • GDM后2型糖尿病的种族和民族不平等显著,分娩时特征可部分解释差异,为干预生命历程心血管代谢不平等提供机会。
  • 黑人、西班牙裔和南亚及东南亚裔中常见社会结构措施和BMI与2型糖尿病关联较弱,表明需更深入理解结构性种族主义如何影响产后心血管代谢风险。

研究设计与样本

  • 回顾性队列研究,链接2009-2011年纽约市出生和医院数据与2009-2017年纽约市A1c登记数据。
  • 分析数据集包括22,338例GDM患者,从出生和医院记录确定GDM及妊娠特征。
  • 2型糖尿病定义为两次血红蛋白A1c检测结果均≥6.5%。

主要发现

  • 8年2型糖尿病总体发病率为11.7%;黑人18.5%、南亚及东南亚裔16.8%、西班牙裔14.6%、东亚及中亚裔5.5%、白人5.4%。
  • 与白人相比,黑人调整风险比4.0(95%CI 2.4-3.9),南亚及东南亚裔2.9(95%CI 2.4-3.3),西班牙裔3.3(95%CI 2.7-4.2),东亚及中亚裔1.0(95%CI 0.9-1.4)。
  • 临床特征和社会结构特征分别解释黑人差异的9.3%和23.8%,西班牙裔的31.2%和24.7%,南亚及东南亚裔的7.6%和16.3%。
  • 教育、医疗补助保险、WIC参与和BMI与2型糖尿病发病的关联在白人中比黑人、西班牙裔和南亚及东南亚裔更明显。

关键数值与推荐

  • 2型糖尿病定义为两次血红蛋白A1c检测结果均≥6.5%。
  • 妊娠特征分为临床特征(体重指数、慢性高血压、妊娠期高血压、子痫前期、早产、剖宫产、母乳喂养、巨大儿、肩难产)和社会或结构特征(教育、医疗补助保险、产前保健、WIC参与)。
  • 使用Cox比例风险模型估计种族和民族与8年2型糖尿病发病率的关联,并检验妊娠特征的中介作用,额外校正年龄和出生地(美国出生 vs 外国出生)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate racial and ethnic disparities in type 2 diabetes mellitus after gestational diabetes mellitus (GDM) and to investigate baseline pregnancy clinical and social or structural characteristics as mediators. METHODS: We conducted a retrospective cohort of individuals with GDM using linked 2009-2011 New York City birth and hospital data and 2009-2017 New York City A1c Registry data. We ascertained GDM and pregnancy characteristics from birth and hospital records. We classified type 2 diabetes as two hemoglobin A 1c test results of 6.5% or higher. We grouped pregnancy characteristics into clinical (body mass index [BMI], chronic hypertension, gestational hypertension, preeclampsia, preterm delivery, caesarean, breastfeeding, macrosomia, shoulder dystocia) and social or structural (education, Medicaid insurance, prenatal care, and WIC [Special Supplemental Nutrition Program for Women, Infants, and Children] participation). We used Cox proportional hazards models to estimate associations between race and ethnicity and 8-year type 2 diabetes incidence, and we tested mediation of pregnancy characteristics, additionally adjusting for age and nativity (U.S.-born vs foreign-born). RESULTS: The analytic data set included 22,338 patients with GDM. The 8-year type 2 diabetes incidence was 11.7% overall and 18.5% in Black, 16.8% in South and Southeast Asian, 14.6% in Hispanic, 5.5% in East and Central Asian, and 5.4% in White individuals with adjusted hazard ratios of 4.0 (95% CI 2.4-3.9), 2.9 (95% CI 2.4-3.3), 3.3 (95% CI 2.7-4.2), and 1.0 (95% CI 0.9-1.4) for each group compared with White individuals. Clinical and social or structural pregnancy characteristics explained 9.3% and 23.8% of Black, 31.2% and 24.7% of Hispanic, and 7.6% and 16.3% of South and Southeast Asian compared with White disparities. Associations between education, Medicaid insurance, WIC participation, and BMI and type 2 diabetes incidence were more pronounced among White than Black, Hispanic, and South and Southeast Asian individuals. CONCLUSION: Population-based racial and ethnic inequities are substantial in type 2 diabetes after GDM. Characteristics at the time of delivery partially explain disparities, creating an opportunity to intervene on life-course cardiometabolic inequities, whereas weak associations of common social or structural measures and BMI in Black, Hispanic and South and Southeast Asian individuals demonstrate the need for greater understanding of how structural racism influences postpartum cardiometabolic risk in these groups.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Janevic T, McCarthy K, Liu SH, et al. Racial and Ethnic Inequities in Development of Type 2 Diabetes After Gestational Diabetes Mellitus. Obstet Gynecol. 2023. PMID: 37678923. doi:10.1097/AOG.0000000000005324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。